Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Passeri

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Neuropeptides|March 1, 1990
Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in manP P Vescovi, G Gerra, L Maninetti, et al.
Bone and Mineral|December 1, 1991
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosisM Passeri, M C Baroni, M Pedrazzoni, et al.
Journal of Internal Medicine|December 1, 1989
Habitual leisure-time physical activity is associated with differences in various risk factors for coronary artery diseaseI Zavaroni, P Angelo Bonati, L Luchetti, et al.
Aging (Milan, Italy)|February 1, 1993
Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter studyM Passeri, D Cucinotta, G Abate, et al.
Acta Endocrinologica|March 1, 1992
Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal womenG Pioli, M Pedrazzoni, E Palummeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
High risk for microcarcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomiesM Carlini, C Giovannini, F Castaldi, et al.
Calcified Tissue International|January 1, 1986
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical studyG F Mazzuoli, M Passeri, C Gennari, et al.
Bone and Mineral|October 1, 1992
Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosisD Agnusdei, S Adami, R Cervetti, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1986
Diagnosis in the Cushing's syndrome revisitedL De Marinis, A Mancini, C D'Amico, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 yearsS Adami, L Bufalino, R Cervetti, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Neuropeptides|March 1, 1990
Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in manP P Vescovi, G Gerra, L Maninetti, et al.
Bone and Mineral|December 1, 1991
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosisM Passeri, M C Baroni, M Pedrazzoni, et al.
Journal of Internal Medicine|December 1, 1989
Habitual leisure-time physical activity is associated with differences in various risk factors for coronary artery diseaseI Zavaroni, P Angelo Bonati, L Luchetti, et al.
Aging (Milan, Italy)|February 1, 1993
Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter studyM Passeri, D Cucinotta, G Abate, et al.
Acta Endocrinologica|March 1, 1992
Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal womenG Pioli, M Pedrazzoni, E Palummeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
High risk for microcarcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomiesM Carlini, C Giovannini, F Castaldi, et al.
Calcified Tissue International|January 1, 1986
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical studyG F Mazzuoli, M Passeri, C Gennari, et al.
Bone and Mineral|October 1, 1992
Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosisD Agnusdei, S Adami, R Cervetti, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1986
Diagnosis in the Cushing's syndrome revisitedL De Marinis, A Mancini, C D'Amico, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 yearsS Adami, L Bufalino, R Cervetti, et al.
Pageof 17